Stock vs Stock Comparison

CVS Health Corporation vs Abbott Laboratories

ABT wins the Tale of the Tape 5–4.

CVS$91.37
ABT$86.99

🏆 Tale of the Tape

45
CVSABT
0.4%Profitability (Net Margin)14.7%
39.9xValuation (P/E)24.0x
2.5%Efficiency (ROIC)10.1%
6/9Health (Piotroski F)5/9
2.3Safety (Altman Z)4.9
7.8%Growth (Rev YoY)5.7%
0.47Risk (Sharpe 1Y)-1.05
2.36xBalance Sheet (D/E)0.64x
5.08%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.128
252-Day Correlation
0.052
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCVSABT
Market Cap$116.1B$149.1B
P/E Ratio39.9x24.0x
Forward P/E10.9x14.1x
P/B1.50x2.86x
Dividend Yield2.92%2.94%
Beta0.590.65

Quantitative Metrics

MetricCVSABT
DCF Fair Value$59.00$57.20
DCF Upside-24.4%-43.2%
Piotroski F6/95/9
Altman Z2.274.87
Beneish M-2.58-2.53
FCF Yield5.08%4.21%
Net Debt/EBITDA5.3x0.1x
ROIC2.5%10.1%
WACC6.5%9.4%
ROIC – WACC-4.0pp0.7pp
Gross Margin13.8%56.4%
Net Margin0.4%14.7%
Rev Growth YoY7.8%5.7%
Sharpe (1Y)0.47-1.05
Max Drawdown 3Y
FCF Payout Ratio44%56%

CVS Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

CVS found in:

IYK4.29%
XLV2.22%
XHS2.21%
VHT1.71%
SPYD1.36%
DVY1.34%
ONEY1.12%
VFVA0.82%
VFMO0.57%
MGV0.53%
VYM0.43%
ONEO0.42%
SPYV0.41%
VTV0.41%
QUS0.34%
SCHV0.34%
VONV0.32%
IWD0.30%
SPY0.19%
RSP0.18%
ESGV0.18%
SPLG0.17%
IVV0.17%
VOO0.17%
SPTM0.17%
SCHX0.16%
VONE0.16%
SCHB0.15%
ITOT0.15%
VTI0.15%
URTH0.12%
ACWI0.10%
VT0.09%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CVS vs ABT: Head-to-Head Analysis

CVS Health Corporation (CVS) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, CVS generates a return on invested capital (ROIC) of 2.5% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between CVS and ABT is 0.128, indicating low correlation, making them an effective diversification pair in a portfolio context.

CVS appears in 33 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CVS or ABT?

Our quantitative analysis compares CVS and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CVS and ABT correlated?

The 252-day correlation between CVS and ABT is 0.128. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.